Cookie policy notice

By continuing to use this site you agree to our cookies policy below:
Since 26 May 2011, the law now states that cookies on websites can ony be used with your specific consent. Cookies allow us to ensure that you enjoy the best browsing experience.

This site is intended for health professionals only

At the heart of general practice since 1960

DH reviews HPV vaccine

The Department of Health will soon announce which vaccine will be used in the next four-year HPV vaccination programme, amid pressure to switch from Cervarix to Gardasil.

In 2008, The Joint Committee on Vaccination and Immunisation recommended Gardasil use, and the BMA is also in favour. Gardasil is known to provide protection for genital warts.

A DH spokesperson said: ‘England has one of the most successful HPV vaccination programmes in the world.'

'Discussions on the new tender are concluding and an announcement will be made in due course.'

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say